01 Jul 2021 Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatments Member news
22 Jun 2021 Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy Member news
15 Jun 2021 Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels Member news
14 Jun 2021 Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics Member news
02 Jun 2021 RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV Member news
11 May 2021 Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski Member news
11 May 2021 Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
